Prognostic Value of T Cell Immunoglobulin Mucin-3 in Prostate Cancer |
Piao, Yong-Rui
(Department of Urology, Affiliated Hospital of YanBian University)
Piao, Long-Zhen (Department of Oncology, Affiliated Hospital of YanBian University) Zhu, Lian-Hua (Department of Dermatology and Venereology, Affiliated Hospital of YanBian University) Jin, Zhe-Hu (Department of Dermatology and Venereology, Affiliated Hospital of YanBian University) Dong, Xiu-Zhe (Department of Urology, Affiliated Hospital of YanBian University) |
1 | Abildgaard MO, Borre M, Mortensen MM, et al (2012). Downregulation of zinc finger protein 132 in prostate cancer is associated with aberrant promoter hypermethylation and poor prognosis. Int J Cancer, 130, 885-95. DOI ScienceOn |
2 | Cai C, Wang L, Wu Z, et al (2012). T-cell immunoglobulin- and mucin-domain- containing molecule 3 gene polymorphisms and renal cell carcinoma. DNA Cell Biol, 31, 1285-9. DOI ScienceOn |
3 | Facompre N, El-Bayoumy K (2009).Potential stages for prostate cancer prevention with selenium: implications for cancer survivors. Cancer Res, 69, 2699-703. DOI ScienceOn |
4 | Fourcade J, Sun Z, Benallaoua M, et al (2010). Upregulation of Tim-3 and PD-1 expression is associated with tumor antigenspecific CD8+T cell dysfunction in melanoma patients. J Exp Med, 207, 2175-86. DOI ScienceOn |
5 | Geng H, Zhang GM, Li D, et al (2006). Soluble form of T cell Ig mucin 3 is an inhibitory molecule in T cell-mediated immune response. J Immunol, 176, 1411-20. DOI |
6 | Huang X, Bai X, Cao Y, et al (2010). Lymphoma endothelium preferentially expresses TIM-3 and facilitates the progression of lymphoma by mediating immune evasion. J Exp Med, 207, 505-20. DOI ScienceOn |
7 | Jan M, Chao MP, Cha AC, et al (2011). Prospective separation of normal and leukemic stem cells based on differential expression of Tim-3, a human acute myeloid leukemia stem cell marker. Proc Natl Acad Sci, 108, 5009-14. DOI ScienceOn |
8 | Jemal A, Siegel R, Xu J, Ward E (2010). Cancer statistics, 2010. CA Cancer J Clin, 60, 277-300. DOI |
9 | Kikushige Y, Shima T, Takayanagi S, et al (2010). Tim-3 is a promising target to selectively kill acute myeloid leukemia stem cells. Cell Stem Cell, 7, 708-17. DOI ScienceOn |
10 | Sakuishi K, Apetoh L, Sullivan JM, et al (2010). Targeting TIM-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity. J Exp Med, 207, 2187-94. DOI ScienceOn |
11 | Sugiyama Y, Masumori N, Fukuta F, et al (2013). Influence of isoflavone intake and equol-producing intestinal flora on prostate cancer risk. Asian Pac J Cancer Prev, 14, 1-4. 과학기술학회마을 DOI ScienceOn |
12 | Wiener Z, Kohalmi B, Pocza P, et al (2007). TIM-3 is expressed in melanoma cells and is upregulated in TGF-beta stimulated mast cells. J Invest Dermatol, 127, 906-14. DOI ScienceOn |
13 | Xu LW, Qian M, Jia RP, et al (2012). Expression and significance of microsomal prostaglandin synthase-1 (mPGES-1) and Beclin-1 in the development of prostate cancer. Asian Pac J Cancer Prev, 13, 1639-44. 과학기술학회마을 DOI ScienceOn |
14 | Yang X, Liang L, Zhang XF, et al (2013). MicroRNA-26a suppresses tumor growth and metastasis of human hepatocellular carcinoma by targeting IL-6-Stat3 pathway. Hepatology, 58, 158-70. DOI ScienceOn |
15 | Zhuang X, Zhang X, Xia X, et al (2012). Ectopic expression of TIM-3 in lung cancers: a potential independent prognostic factor for patients with NSCLC. Am J Clin Pathol, 137, 978 - 85. DOI ScienceOn |
16 | Yun UJ, Park SE, Jo YS, Kim J, Shin DY (2012). DNA damage induces the IL-6/STAT3 signaling pathway, which has anti-senescence and growth-promoting functions in human tumors. Cancer Lett, 323, 155-60. DOI ScienceOn |
![]() |